"Hipertensão Arterial Refratária"

• Dr. Fernando Antonio Almeida
• Dr. Luiz Aparecido Bortolotto

1. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 45:479-86.

2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.

3. Almeida FA, Santana IMC, Faria CSD, Almeida JPG, Reis MA, Camargo MN, Almeida JR, Rocha MCP, Cadaval RAM, D’Ávila R, Rodrigues CIS. O conhecimento sobre a doença do paciente com hipertensão arterial das Unidades Básicas de Saúde (UBS). IX Encontro Paulista de Nefrologia, J Bras Nefrol 2003;24 (Supl 1): 41 (abstract).

4. Vidt DG. Resistant hypertension. In Hypertension: A Companion to Brenner and Rector’s The Kidney. Eds: Oparil S, Weber MA. Philadelphia, WB Saunders Company; 2000, p.564-572.

5. Swales JD, Bing RF, Heagerty A, Pohl J, Russel GI, Thursten H. Treatment of refractory hypertension. Lancet 1982; 1: 894-6

6. Alderman MH, Budner N, Cohen H, Lamport B, Ooi WL. Prevalence of drug resistant hypertension. Hypertension 1988; 11 (Suppl II: II71-II75

7.Staessen JÁ, Fagard R, Thijs L, et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1999, 350: 757-64

8.Cushman WC, Black HR, Probstfield JL, et al. for the ALLHAT Group. Blood pressure control in the Antihypertensive and Lipid Lowering treatment to Prevent Heart Attack (ALLHAT). Am J Hypertens 1998, 11: 17A

9. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991;151(9):1786-92.

10. IV Diretrizes Brasileiras de Hipertensão Arterial. Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Cardiologia e Sociedade Brasileira de Nefrologia. Rev Bras Hiperten 2002;9:359-408.

11 Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens 2003; 21 (Suppl 2):S37-S42.

12. Armstrong EP, Malone DC. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther 2003;25(1):1-18.

13. Morgan TO, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000;13(11):1161-7.

14. Whelton A, White WB, Bello AE, Puma JA, Fort JG; SUCCESS-VII Investigators. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol 2002; 90(9):959-63.

15. Martell N, Rodriguez-Cerrillo M, Grobbee DE, Lopez-Eady MD, Fernandez-Pinilla C, Avila M, Fernandez-Cruz A, Luque M. High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension. Blood Press 2003;12(3):149-54.

16. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How commom is white coat hypertension? JAMA 1988; 259: 225-8

17. Glen SK, Elliot HL, Curzio JL, Lees KR, Reid JL. White coat hypertension as a cause of cardiovascular dysfunction . Lancet 1996; 348: 654-7

18. Taguchi JT, Suwangool P. "Pipe-stem" brachial arteries. A cause of pseudohypertension. JAMA 1974; 228: 733

19. Wright JC, Looney SW. Prevalence of positive Osler´s manoeuver in 3387 persons screened for the Systolic Hypertension in the Elderly Program (SHEP). J Hum Hypertens 1997; 11: 285-289

20.Messerli FH, Ventura HO, Amodeo C. Osler´s manoeuver and pseudohypertension. N Engl J Med 1985; 312: 1548-51

21. Anzal M, Palmer AJ, Starr J, Bulpit CJ. The prevalence of pseudohypertension in the elderly. J Hum Hypertens 1996; 10: 409-11

22. Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements-an aid to diagnosis? Clin Exp Hypertens A 1991;13(6-7):1195-212.

23. Silverberg DS, Oksenberg A, Iaina A. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am J Hypertens 1997;10(12 Pt 1):1319-25.

24. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002;39(5):982-8.

25. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.

26. Ouzan J, Perault C, Lincoff AM, Carre E, Mertes M. The role of spironolacone in the treatment of patients with refractory hypertension. Am J Hypertens 2002; 15: 333-9.